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Abstract
Oxysterol-binding protein (OSBP) homologues, ORPs, are implicated in lipid homeostatic control, vesicle transport, and cell
signaling. We analyzed here the quantity of ORP mRNAs in human subcutaneous (s.c.) and visceral adipose depots, as well
as in the Simpson-Golabi-Behmel syndrome (SGBS) adipocyte cell model. All of the ORP mRNAs were present in the s.c and
visceral adipose tissues, and the two depots shared an almost identical ORP mRNA expression pattern. SGBS adipocytes
displayed a similar pattern, suggesting that the adipose tissue ORP expression pattern mainly derives from adipocytes.
During SGBS cell adipogenic differentiation, ORP2, ORP3, ORP4, ORP7, and ORP8 mRNAs were down-regulated, while ORP11
was induced. To assess the impacts of ORPs on adipocyte differentiation, ORP3 and ORP8, proteins down-regulated during
adipogenesis, were overexpressed in differentiating SGBS adipocytes, while ORP11, a protein induced during adipogenesis,
was silenced. ORP8 overexpression resulted in reduced expression of the aP2 mRNA, while down-regulation of adiponectin
and aP2 was observed in ORP11 silenced cells. Furthermore, ORP8 overexpression or silencing of ORP11 markedly decreased
cellular triglyceride storage. These data identify the patterns of ORP expression in human adipose depots and SGBS
adipocytes, and provide the first evidence for a functional impact of ORPs on the adipocyte phenotype.
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Introduction
Bioactive lipid signaling molecules are key players in cell
regulation, and disturbances in signaling lipids such as oxysterols,
sphingolipids/ceramides, fatty acid derivatives and diacylglycerols,
are associated with metabolic and cardiovascular diseases [1–3].
Oxysterols are 27-carbon oxygenated products of cholesterol
that arise through enzymatic or non-enzymatic oxidation process-
es, or are absorbed from the diet [4,5]. As ligands of sterol-
regulated transcription factors and intermediates in the biosyn-
thesis of bile acids and steroid hormones, oxysterols control gene
expression in lipid metabolism, regulate immune and inflamma-
tory responses, and modify cellular calcium signaling [4,6,7].
Oxysterols are present at low concentrations in tissues and their
circulating concentrations are altered in obesity, metabolic
syndrome and cardiovascular disease [8–12]. However, there is
very limited information available on the role of oxysterols or the
proteins mediating their biological effects in adipose tissue [13].
Wamil et al. [14] reported that the oxysterol 7-ketocholesterol
inhibits the activity of glucocorticoids and impairs the differenti-
ation of mouse 3T3-L1 adipocytes, while Kha et al. [15] failed to
observe this effect in human mesenchymal stem cells. 22(R)-,
20(S)- and 20(S)-hydroxycholesterol (OHC) were found to inhibit
adipocytic and to promote osteogenic differentiation of the stem
cells through the Hedgehog signaling pathways [15–18]. Further-
more, Baranova et al. [19] found that CH25H, a cholesterol
hydroxylase catalysing oxysterol synthesis, was significantly down-
regulated in the visceral adipose tissue of obese individuals in
comparison to non-obese ones, suggesting a distinct functional role
of 25-OHC in adipose tissue.
Oxysterol-binding protein (OSBP) and its homologues desig-
nated OSBP-related proteins (ORPs) are lipid binding proteins,
the b-barrel-like ligand-binding domain of which can accommo-
date lipids such as oxysterols, cholesterol, or phosphatidylinositol-
4-phosphate [20–22]. They are proposed to regulate cellular lipid
homeostasis and to act as sterol transporters and signaling sensors.
OSBP, the founder member of the protein family, shows high
affinity for a variety of oxysterols [23]. As a sterol sensor, OSBP
regulates ceramide transport from the endoplasmic reticulum (ER)
to the Golgi apparatus, mediated by the ceramide transporter,
PLOS ONE | www.plosone.org 1 September 2012 | Volume 7 | Issue 9 | e45352
CERT [24,25]. Interestingly, OSBP also acts as a cholesterol-
dependent scaffold for protein phosphatases in the extracellular
signal-regulated kinase (ERK) signaling pathway [26]. Moreover,
OSBP has the capacity to regulate the insulin induction of
SREBP-1c and hepatic lipogenesis [27]. The ORP protein/gene
family in humans and mice consists of a large number of proteins
encoded by 12 genes, which serve diverse functions in cellular lipid
metabolism and signaling [28–30]. Several members of the ORP
family have been putatively connected with metabolic diseases:
ORP8 was suggested to regulate insulin signaling in mouse models
of obesity [31] and lipid levels in mouse plasma and liver tissue
[32]. Interestingly, ORP11 was found to be abundantly expressed
in visceral adipose tissue and was associated with cardiovascular
risk factors in obese subjects with metabolic syndrome [33].
Furthermore, it was reported that the expression levels of
OSBPL11 were significantly different in adipose tissue between
the high and low responders to caloric restriction [34]. However,
there are no data comparing the expression of OSBP/ORP in
human visceral and subcutaneous adipose tissues, or assessing the
functional role of ORPs in adipocytes. In the present study we
analyze the expression patterns of ORP mRNAs in human
subcutaneous and visceral adipose depots, as well as in Simpson-
Golabi-Behmel syndrome (SGBS) cells. These cells represent a
human preadipocyte model that is neither transformed nor
immortalized, shows a high capacity for adipose differentiation,
and is used as a model for normal adipocyte differentiation
[35,36]. Moreover, we examine the functional impacts of selected
ORPs (ORP3, ORP8 and ORP11) on SGBS adipocyte differen-
tiation and triglyceride storage.
Methods
Antibodies and Other Reagents
The rabbit ORP2, ORP3, ORP8 and ORP11 antibodies have
been described previously [37–40]. Rabbit OSBP antibody was a
gift from Dr. Maria Antonietta De Matteis (Telethon Institute of
Genetics and Medicine, Naples, Italy). Anti-ORP9 rabbit antibody
was kindly provided by Prof. N. Ridgway (Dalhousie University,
Halifax, Nova Scotia, Canada). Anti-b-actin and anti-aP2 rabbit
polyclonal antibodies were purchased from Sigma-Aldrich (St.
Louis, MO).
Western Blot Analysis
Protein samples for SDS-PAGE were prepared by homogeniz-
ing cultured cells in 250 mM Tris-HCl, pH 6.8, 8% SDS, protease
inhibitor cocktail (Roche Diagnostics, Mannheim, Germany). The
crude extracts were cleared by centrifugation in a microfuge at
13,000 rpm for 3 min, and the protein concentration of the
supernatants was determined by the DC assay (BioRad, Hercules,
CA). The proteins were electrophoresed on Laemmli gels and
electrotransferred onto Hybond-C Extra nitrocellulose mem-
branes (Amersham Biosciences, Piscataway, NJ) for different
periods of time according to the protein size. Unspecific binding
of antibodies was blocked with, and all antibody incubations were
carried out in 5% fat free powdered milk in 10 mM Tris-HCl,
pH 7.4, 150 mM NaCl, and 0.05% Tween 20. The bound
primary antibodies were visualized with horseradish peroxidase-
conjugated goat anti-rabbit IgG (Bio-Rad) and the enhanced
chemiluminescence system (Thermo Scientific, Rockford, IL). The
expression levels were quantified by densitometry using ImageJ
(http://rsbweb.nih.gov/ij/), and the data was normalized accord-
ing to the b-actin signal.
Cell Culture and Lentiviral/adenoviral Transduction
Human Simpson-Golabi-Behmel syndrome (SGBS) pre-adipo-
cytes [35,36] were cultured in Dulbecco’s modified Eagle’s
medium (DMEM)/Ham’s F12 medium (Invitrogen, Paisley, UK)
containing 10% fetal bovine serum (FBS; Sigma-Aldrich), 66 nM
biotin (Sigma-Aldrich), 33 nM D-pantothenic acid (Sigma-Al-
drich) and 2% penicillin/streptomycin. Cells were seeded onto 12-
well plates and grown to 80%–90% confluency for differentiation.
To induce differentiaton, the cells were washed three times with
PBS and changed to serum-free DMEM/F12 medium supple-
mented with 0.01 mg/ml human apo-transferrin (Sigma-Aldrich),
20 nM insulin, 100 nM cortisol (Sigma-Aldrich), 0.2 nM triiodo-
thyronine (Sigma-Aldrich), 25 nM dexamethasone (Sigma-Al-
drich), 250 mM 1-methyl-3-isobutyl-xanthine (IBMX, (Sigma-
Aldrich) and 2 mM rosiglitazone (Sigma-Aldrich) for 4 days. The
cells were subsequently differentiated in serum-free DMEM/F12
medium containing 20 nM insulin, 100 nM cortisol, and 0.2 nM
triiodothyronine for additional 18 days. The differentiation was
monitored by quantifying Oil Red O stainable lipid droplets and
by measuring by qPCR the mRNA levels of PPARc, aP2, leptin,
and adiponectin.
pGIPZ-ORP11 shRNA construct (Cat. no. RHS4430-
98704927) and pGIPZ empty vector were purchased from
OpenBioSystems/Thermo Scientific (Huntsville, AL). Lentiviral
particles were generated by transfection of the shRNA and
packing plasmids pHelper and pEnvelope to HEK 293FT cells
using the FuGENE HD Reagent (Roche Diagnostics). After three
days’ transfection, the viral supernantant was filtered through a
0.45 mm PVDF filter and further concentrated by ultracentrifu-
gation for 2 hrs in an SW28 rotor at 19,400 rpm, 4uC. ORP3 and
ORP8 adenoviruses were produced as described [32,41]. SGBS
preadipocytes were transduced with the shRNA lentiviruses in the
presence of 8 mg/ml hexadimethrine bromide, followed by
0.5 mg/ml puromycine antibiotic selection of stable cell pools.
For adenoviral transduction, SGBS adipocytes were transiently
transduced for 72 hrs at a m.o.i. of 50 I.U./cell, on day 10 during
the differentiation. The silencing or overexpression of target ORPs
was verified by qPCR and Western blotting.
Bioinformatics Analysis of ORP mRNA Expression
The microarray dataset of Human U133A/GNF1H Gene Atlas
from BioGPS web site (http://biogps.org/downloads/) was used
for the analysis. We focused on the OSBP/ORP probe sets in
different tissues; their information was extracted separately. Some
probe sets judged to be non-functional were eliminated if their
signals were throughout the tissue selection at or close to the
median value across all the samples for the specific probe set. The
functionality of probe sets was further critically evaluated based on
a comparison to the published results on ORP mRNA or protein
expression.
Human Adipose Tissue Specimens
Human subcutaneous and visceral adipose tissue specimens
were obtained from four morbidly obese patients upon bariatric
surgery at Peijas Hospital, Finland. The patients were female and
their ages ranged from 33 to 64 yrs. Their average BMI was
averaged 46.9 kg/m2 (range 43.7 to 50.8 kg/m2) and waist to hip
ratio 0.91 (range 0.88–0.96).
The subjects were volunteers recruited according to a permis-
sion (28/13/03/02/2010) from the Medicinal Ethics Committee
of the Helsinki and Uusimaa Hospital Distric. The Finnish Ethics
Committees obey the current Finnish law. The Medical Research
Act No. 488/1999 takes into consideration statutory regulations
and directives (Mostly Directives 2001/20/EC and 2005/28/EC)
OSBP-Related Proteins in Adipocytes
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within EC area. The Ethics committee operates according to the
principles of good clinical research practice (ICH-GCP-E6) and in
accordance with the international obligations concerning the
status of re- search subjects and the rules and guidelines that
govern research (Medical Research Act 488/1999, chapter 2 a
(23.4.2004/295), section 5 and 10a). The Medicinal Ethics
Committee of the Helsinki and Uusimaa Hospital District is
registered with the HHS and follows ICH-GCP-E6 in reviewing
all research in the Helsinki and Uusimaa Hospital District
involving human subjects. Minerva Foundation Institute for
Medical Research does not have its own ethics committee. All
clinical research carried out by Minerva researchers occurs at the
clinics of the Helsinki and Uusimaa Hospital District, and ethical
approvals for these studies have to be exclusively obtained from
the Medicinal Ethics Committee of this Hospital District. No
research was conducted outside our country of residence. The
patients signed a written consent after receiving detailed informa-
tion on the study protocol and after having an adequate time for
deliberation. All procedures and possible hazards, risks and
discomforts were explained to the subjects both orally and in
writing. The signed forms are archived in our study documenta-
tion.
Quantitative RT-PCR (qPCR) Analyses
Total RNA (RNeasy Lipid Tissue Mini kit, QIAGEN, German-
town, MD) was extracted from s.c. and visceral adipose tissues of 4
patients. The RNAs were reverse transcribed by using the VILO
kit (Invitrogen, Carlsbad, CA) and subjected, by using primer sets
specific for 13 major ORP transcripts (Table 1), to qPCR analysis
using SYBR Green I Master Mix (Roche Diagnostics) and a
Roche LightCycler 480 II instrument.
Human ORP open reading frames were cloned into pcDNA4-
HisMaxC (Invitrogen, Carlsbad, CA) as described before [38–
40,42,43]. pEGFP-OSBP was a gift from Dr. Maria Antonietta De
Matteis (Telethon Institute of Genetics and Medicine, Naples,
Italy). The full-length ORP cDNA inserts were excised from the
constructs and used as calibrators to quantify the corresponding
mRNA copy numbers in human adipose specimens and SGBS
adipocytes. A copy number standard curve was created from a
dilution series of each ORP cDNA and used as a reference
template in the same PCR runs. CT values given by the tissue and
SGBS cells were further converted to copy numbers using the
standard curve [42]. Relative mRNA quantification of ORPs,
adiponectin, aP2, leptin, and PPARc was carried out by using the
DDCT method with succinate dehydrogenase subunit alpha
(SDHA) and b-actin as reference housekeeping mRNAs (Table 1).
Oil Red O Staining of Neutral Lipids
Cells were washed with PBS, fixed by using 10% formalin for
30 min and then gently rinsed with water. After incubation with
60% isopropanol for 5 min, the cellular neutral lipids were stained
by using 1.8 mg/ml Oil Red O in 60% isopropanol. Cells were
rinsed with water and stained by using Hematoxylin at room
temperature for 1 min.
Assay for Cellular Triglyceride Content
After lentiviral or adenoviral transduction, SGBS adipocytes
were lysed in RIPA buffer containing 50 mM Tris-HCl (pH 7,4),
1% NP-40, 0.25% Na-deoxycholate, 150 mM NaCl, 1 mM
EDTA, 1% SDS and protease inhibitor cocktails (Roche
Diagnostics). The supernatant was harvested after centrifugation
for 5 min, and 10 ml samples as well as the glycerol standards
(2300, 1150, 575, 287.5, 143.75 and 71.88 mmol/L) were
subsequently mixed with 200 ml of the GPO-PAP Triglyceride
kit (Cobas, Roche/Hitachi) reagent on a 96-well plate. After
incubation at room temperature for 20 min, colorimetric assay
was performed at 510 nm by using a Victor multilabel analyzer
(Wallac, Turku, Finland). The triglyceride concentrations were
Table 1. Oligonucleotide primers for mRNA quantification by quantitative real-time reverse transcription-PCR.
mRNA Forward primer 59-39 Reverse primer 59-39
OSBP GATCCATCAGGAAAAGTCCAC CAGTGCCACTTTCCCAAGCA
ORP1S GGTCCTCGGATCTGGCCCA ACTCAGGGACCTTTCGGACTC
ORP1L TGATTGCCTTAATCTCTTCACC ACTCAGGGACCTTTCGGACTC
ORP2 ACCACCTGAGAAAGGCCAAGC CTCCAGCTCGTTGAGGCTCAC
ORP3 GCATCTAGCTACTACCGAGCT CACATGGGTTGTGCCAATTGGA
ORP4 AAGCTCTGGATCGACCAGTCA CTGGGACTGCTATGCATGACC
ORP5 GTGCCGCTGGAGGAGCAGAC AGGGGCTGTGGTCCTCGTATC
ORP6 GGATACTGCTCCACCTATTTCA ACAGGCAGGATTTCCATCGAC
ORP7 CGGCCTACTCCTCCACATACC ACTGTTCCCACAGGCACAATC
ORP8 GAAGAACAGGGAGATTTTGAATCA TCCTGTGAGTGGATCAAGTTC
ORP9 CATCTTCCACACTAAACCCTTC CTCGTTCTGATCTTCCAACTTC
ORP10 CTCAGCGACAGTGATATTCCAC AGGTCTGATCTTCTTGGGATAC
ORP11 CACATTTTCTCTACCCTGTGCA CCCTTGCACTCTGCATACCAC
Adiponectin GGCCGTGATGGCAGAGAT CCTTCAGCCCGGGTAC
aP2 GCTTTTGTAGGTACCTGGAAACTT ACACTGATGATCATGTTAGGTTTGG
Leptin GCCCTATCTTTTCTATGTCC TCTGTGGAGTAGCCTGAAG
PPARc GATCCAGTGGTTGCAGATTACAA GAGGGAGTTGGAAGGCTCTTC
SDHA CATGCTGCCGTGTTCCGTGTGGG GGACAGGGTGTGCTTCCTCCAGTGCTCC
b-actin GACAGGATGCAGAAGGAGATT TGATCCACATCTGCTGGAAGG
doi:10.1371/journal.pone.0045352.t001
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normalized for total cell protein determined with the DC assay
(BioRad).
Statistical Analysis
The data are presented as mean 6 standard error of mean
(SEM). Student’s T-test was applied for comparisons between
Figure 1. Copy numbers of OSBP/ORP mRNAs in human adipose tissues and SGBS adipocytes. The mRNAs were quantified by qPCR
using the corresponding cDNAs as calibrators (see Materials and Methods), and the mRNA quantities are presented on a log10 scale as copies/ng
total RNA. A. Subcutaneous adipose tissue; B. Visceral adipose tissue. The data represents mean 6 S.E., n = 4. C. Simpson-Golabi-Behmel syndrome
(SGBS) adipocytes after 22-day differentiation. The mean from a single experiment carried out in triplicate is shown.
doi:10.1371/journal.pone.0045352.g001
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groups of data points. All statistical tests were two-sided and
p values ,0.05 were considered significant.
Results
OSBP/ORP Copy Numbers in Human Adipose Depots and
SGBS Adipocytes
OSBP/ORP mRNA copy numbers were determined in s.c. and
visceral adipose tissue biopsy specimens from 4 obese female
patients as well as in SGBS adipocytes. The OSBP/ORP
expression patterns of the s.c. and visceral fat depots were almost
identical (Fig. 1A, B), and the SGBS adipocytes displayed a highly
similar pattern (Fig. 1C), consistent with the view that the mRNA
signals in human adipose tissue specimens mainly derive from
adipocytes, while the adipose tissues also contain significant
numbers of other cell types such as fibroblasts, macrophages,
and endothelial cells [44], the ORP mRNAs of which could
disturb interpretation of the expression data. Of the ORPs the
mRNAs of which were abundant in the adipose depots, we were
able to detect by Western blotting of total protein specimens
OSBP, ORP2, ORP8, and ORP9, at relatively equal levels in the
two depots (Fig. 2). Even though the ORP11 mRNA was present
at relatively low levels in the adipose tissues, the protein was
detectable on Western blots due to the high sensitivity of our
antiserum.
By applying Human U133A/GNF1H Gene Atlas dataset, we
investigated OSBP/ORPs expression profiles across the human
tissues with the help of a heat-map (Fig. S1). This data set suggests,
in accordance with earlier reports [45,46], that many ORP
mRNAs, such as OSBP, ORP4, and ORP9, are expressed at
relatively even levels in a wide variety of tissues and cell types. The
analysis also suggested that, even though the ORP11 mRNA is not
abundant in adipose tissues on an absolute scale, it is present in
adipocytes at markedly higher levels than in the other tissues/cell
types, with the exception of CD14(+) monocytes, in which the
message also is abundant.
OSBP/ORP Expression during SGBS Adipocyte
Differentiation
To assess the OSBP/ORP expression level during adipocyte
differentiation, we employed the SGBS preadipocyte-adipocyte
model. After 22 days of differentiation, approximately 80% of the
cells were filled by large lipid droplets (Fig. 3A,B). As molecular
markers for adipocytic differentiation, we monitored by qPCR the
expression levels of adiponectin, aP2, leptin and PPARc; These
mRNAs increased dramatically during the 22-day incubation
(Fig. 3C), similar to previous reports [35,36], evidencing for
successful adipogenic differentiation.
We analyzed ORP mRNA relative quantities in the preadipo-
cytes and adipocytes on day 22. Quantitative RT-PCR analyses
revealed that the ORP2 (254%), ORP3 (286%), ORP4 (274%),
ORP7 (256%), and ORP8 (267%) messages were significantly
down-regulated during SGBS cells adipogenesis, while the ORP11
mRNA was elevated 3.5-fold (Fig. 4A). Of these we selected for
further functional analysis ORP3, ORP8, and ORP11, which we
have investigated in detail in previous studies [32,39–41], and for
which we have high quality molecular and immunological tools
available. The observed changes in ORP3, ORP8 and ORP11
expression were confirmed at the protein level by Western blotting
(Fig. 4B). Here, we observed upon SGBS adipocytic differentiation
a 2-fold increase of ORP11 protein, a 55% reduction of ORP8,
and a 60% reduction of ORP3 (Fig. 4C).
Time Course of ORP3, ORP8 and ORP11 Expression
Changes
To determine the time course of the alterations in the mRNA
levels of ORP3, ORP8, and ORP11 during SGBS cell adipogen-
esis, we analyzed the mRNA expression levels on days 0, 4, 10, 14,
16, 18, and 22 of differentiation. The number and size of lipid
droplets in the SGBS cells increased gradually (Fig. 5A). ORP3
and ORP8 were significantly down-regulated already between
days 0 and 4, and no further decrease was detected at the later
time points. In contrast, the ORP11 mRNA was found to be
induced at late time points, the elevation occurring between days
16 and 22 (Fig. 5B).
Effects of ORP Silencing/overexpression on Adipocyte
Differentiation
To elucidate whether ORP3, ORP8, and ORP11 influence
adipogenesis in SGBS cells, we silenced ORP11, the protein up-
regulated upon SGBS adipocyte differentiation, by using a
lentiviral shRNA expression vector. Correspondingly, we overex-
pressed two ORPs down-regulated upon adipocyte differentiation,
ORP3 and ORP8, by using recombinant adenoviral vectors.
We first established SGBS preadipocytes transduced with a
lentivirus expressing ORP11 shRNA; 60–70% reduction of the
ORP11 protein was observed in SGBS adipocytes differentiated
from the transduced preadipocytes, as compared to the controls
transduced with a non-targeting shRNA lentivirus (Fig. 6A). When
these cells were differentiated for 22 days, and the mRNAs for the
adipogenesis markers were quantified, we observed a significant
reduction of adiponectin and aP2 mRNAs in the ORP11 knock-
down cells as compared to the controls (Fig. 6B). Reduction of
ORP11 did not significantly alter the mRNA expression of ORP3
or ORP8.
ORP3 or ORP8 were overexpressed for 3 days starting on day
10 of SGBS adipocytic differentiation, a time at which the
endogenous ORP3 and 28 mRNAs were firmly down-regulated
and the cytoplasmic lipid droplets were rapidly growing (see Fig. 5).
The transduction resulted in a robust increase of the cellular
ORP3 or ORP8 proteins (Fig. 6A). ORP8 overexpression resulted
in a significant down-regulation of the aP2 mRNA (by 61%), as
compared to cells transduced with a control adenovirus. However,
ORP3 overexpression did not significantly affect the adipogenesis
marker mRNA levels (Fig. 6B).
To monitor the putative impacts of the ORP manipulations on
the hallmark of the adipocyte phenotype, neutral lipid accumu-
lation, we quantified triglyceride concentrations in SGBS cells in
which ORP11 was silenced, on day 22 of differentiation, and in
Figure 2. Detection of ORP proteins in human subcutaneous
(S.C.) and visceral adipose tissue specimens. Protein extracts of
human adipose tissues (20 mg/lane) were resolved on SDS-PAGE and
analyzed by Western blotting with antibodies against OSBP, ORP2,
ORP8, ORP9, ORP11, and b-actin, as indicated.
doi:10.1371/journal.pone.0045352.g002
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cells transduced for 3 days with ORP3 or ORP8 adenoviruses as
specified above. This analysis revealed that silencing of ORP11
and overexpression of ORP8 markedly (by .50%) reduced the
storage of cellular triglycerides as compared to cells transduced
with the appropriate control viruses, while ORP3 overexpression
Figure 3. Adipogenic differentiation of SGBS cells. Haematoxylin and Oil Red O staining of SGBS preadipocytes (A) and adipocytes
differentiated for 22 days (B). C. Relative mRNA levels of the adipocyte differentiation markers adiponectin, aP2, leptin and PPARc in SGBS adipocytes
as compared to preadipocytes. The bars indicate fold-change, mean 6 S.E. (n = 3).
doi:10.1371/journal.pone.0045352.g003
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did not significantly influence the cellular triglyceride accumula-
tion (Fig. 6C).
Discussion
Members of the ORPs family are thought to act as sterol sensors
that relay information to the cellular machineries maintaining lipid
homeostasis, energy balance and cell signaling. In the present
study, we describe OSBP/ORP expression patterns in human
adipose depots and SGBS preadipocytes/adipocytes. Further-
more, we present evidence for a functional impact of ORPs on the
adipocyte phenotype.
OSBP/ORPs displayed a similar expression pattern in subcu-
taneous and visceral adipose tissues from morbidly obese patients.
However, the expression profiles across different ORPs were
markedly uneven, and resembled that in SGBS adipocytes. This
suggests that the distinct ORP expression pattern observed in the
human adipose tissues mainly reflects the adipocytic ORP profile,
and is not strongly disturbed by other cell types present in the fat
tissues, such as fibroblasts, macrophages, and endothelial cells
[44]. Bioinformatic analysis suggested that, despite a relatively low
mRNA copy number, ORP11 has an expression hotspot in
adipocytes, unlike the other ORPs. In keeping with this, ORP11
mRNA and protein concentrations were up-regulated upon SGBS
cell adipocytic differentiation while ORP2, ORP3, ORP4, ORP7
and ORP8 mRNAs (verified for ORP3 and ORP8 also at the
protein level) were found to be down-regulated in the SGBS
adipocytes as compared to preadipocytes.
ORP11 was reported to be up-regulated in the visceral adipose
tissue of obese Canadian men with metabolic syndrome compared
to men without the metabolic syndrome [33]. We have previously
found ORP11 to localize at the Golgi-late endosome interface in
HEK293 cells, and demonstrated its interaction with the related
ORP9 [40], a protein implicated in sterol sensing or transport
between the endoplasmic reticulum and the Golgi complex [47].
However, the precise function of ORP11 remains poorly
understood. Knock-down of ORP11 in the SGBS cell model
resulted in decreased expression of adiponectin and aP2.
Adiponectin is an adipokine highly expressed in the white adipose
tissue. Because of its protective role against chronic inflammation,
insulin resistance, weight gain, obesity and cardiovascular disease,
adiponectin is evaluated as an important potential target for
therapy development [48]. aP2, also designated as FABP4, is a 15-
kD cytosolic fatty acid binding protein present in adipocytes and
macrophages. The protein plays a key role in glucose and lipid
homeostasis, and its expression is regulated by fatty acids and
insulin [49–51]. The expression level of aP2 was suggested to
predict the risk of metabolic syndrome, type 2 diabetes and the
development of atherogenic dyslipidemia [52–54]. In addition to
impacts on adiponectin and aP2 expression, silencing of ORP11
resulted in an impairment of triglyceride storage in the SGBS
adipocytes. During the SGBS differentiation time course, ORP11
was induced at late time points (16–22 days). Therefore, ORP11
most likely plays a role during late stages of adipogenic
differentiation and possibly in the maintenance of the mature
adipocyte phenotype.
ORP8 is abundantly expressed in CD14(+) monocytes (Fig. S1)
and in tissue macrophage [39], bringing up the possibility that its
expression in the adipose depots of the patients studied could in
part derive from monocyte-macrophages abundant in the
inflamed adipose tissue of obese subjects [55]. However, the
abundant expression of ORP8 mRNA we detected in SGBS
adipocytes and the data at Human U133A/GNF1H Gene Atlas
suggest that the human adipose depot ORP8 mRNA derives to a
large extent from adipocytes. Together with our recent data on
ORP8 function [32,56,57], these observations suggest that the
protein mediates lipid signals and fine-tunes the adipocyte lipid
metabolism. Consistent with this notion, ORP8 overexpression in
adipocytes significantly reduced the mRNA expression of aP2 and
attenuated cellular triglyceride storage. Interestingly, Jordan et al.
Figure 4. Changes in ORP mRNA and protein expression upon SGBS cell adipogenic differentiation. A. Quantities of the indicated ORP
mRNAs on day 22 of differentiation. The results are presented as fold change relative to preadipocytes. The data represents mean 6 S.E., n = 324,
*p,0.05, **p,0.01. B. Western blot analysis of the ORP11, ORP8, and ORP3 proteins in SGBS preadipocytes and adipocytes (day 22). C. Quantification
of the Western data by densitometric analysis. The ORP11, ORP8 and ORP3 signals were normalized for that of b-actin. The data represents mean 6
S.E., n = 324, *p,0.05.
doi:10.1371/journal.pone.0045352.g004
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[31] reported that ORP8, as a target of miR-143, has a function in
insulin signaling in mouse hepatocytes. These observations are
consistent with the idea that ORP8 manipulation may, via
modification of membrane microdomain organization, impact
signal transduction events. We therefore envision that ORP8
overexpression might attenuate insulin stimulation of the adipo-
genic process. Further studies on the putative connection of ORP8
with the insulin signaling pathways in adipocytes are therefore
warranted.
ORP3 overexpression did not significantly alter the adipocyte
differentiation marker mRNA levels or the triglyceride storage in
SGBS adipocytes. This speaks against an important role of ORP3
in the control of adipocyte differentiation. We previously
characterized ORP3 as a phosphoprotein involved in cell
adhesion, capable of modifying integrin activity, the actin
cytoskeleton, and phagocytosis [41]. In contrast to the down-
regulation of ORP3 we observed upon SGBS adipocyte differen-
tiation, Lee et al. [58] found the protein up-regulated in adipocytes
Figure 5. Time course of ORP11, ORP3, and ORP8 mRNA changes upon SGBS cell adipogenic differentiation. A. Phase contrast images
of SGBS preadipocytes (0 D) and differentiating adipocytes on days 10, 14, and 22. Bars, 200 mm. B. The ORP mRNA levels were quantified at the
differentiation time points indicated, as fold changes relative to preadipocytes (day 0). The data represents mean 6 S.E., n = 3.
doi:10.1371/journal.pone.0045352.g005
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differentiated from human mesenchymal stem cells. The apparent
inconsistency between their and our findings is most likely due to
the use of different cell models: Consistent with the data in [58],
ORP3 was also in our study among the ORPs expressed
abundantly in the s.c. and visceral adipose depots, as well as in
the SGBS adipocytes, even though we detected its moderate
down-regulation during SGBS preadipocyte conversion into
adipocytes. We thus find it likely that induction of ORP3 occurs
Figure 6. Impacts of ORP manipulation on SGBS cell adipogenic differentiation. ORP8 or ORP3 were overexpressed by infecting cells on
day 10 with control (Blank) or ORP (Ad-ORP8, Ad-ORP3) adenoviral vectors, and collected for analysis on day 13. SGBS preadipocytes were transduced
with an ORP11 shRNA (Sh-ORP11) or non-targeting (Sh-NT) shRNA lentivirus, followed by differentiation for 22 days. A. Western blots of total cell
protein (10 mg/lane); ORP11, after 22 days of differentiation; ORP8 and ORP3, after 72 h of adenoviral transduction. The blots were probed with anti-
b-actin as a loading control. B. The impacts of ORP11 silencing or ORP8/ORP3 overexpression on the mRNA levels of adipocyte differentiation markers
adiponectin, aP2, leptin and PPARc. In cells with ORP11 stably silenced also ORP8 and ORP3 mRNAs were quantified. The results are shown as fold
changes relative to cells infected with the corresponding control viruses, and represent mean 6 S.E., n = 3; *p,0.05. C. The cellular triglyceride
concentration was measured by using an enzymatic assay. The results were normalized for total cell protein and are presented relative to cells
infected with the corresponding control viruses (mean 6 S.E., n = 3; *p,0.05, **p,0.01).
doi:10.1371/journal.pone.0045352.g006
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in the adipocyte lineage between the mesenchymal stem cell and
the preadipocyte stages [59]. Both ORP3 and ORP8 were down-
regulated on the very first days of SGBS cell adipocytic
differentiation. This may relate to the cessation of cell proliferation
occuring at this stage – In other words, higher ORP3/ORP8
expression in the preadicytes could be associated with the active
proliferation of these cells.
ORP2 was recently shown to have the capacity to facilitate
cholesterol transfer from the plasma membrane to the endoplas-
mic reticulum and lipid droplets [43]. Moreover, we have earlier
demonstrated localization of ORP2 on cytoplasmic lipid droplets
[60]. However, in the present study we found the ORP2 mRNA
down-regulated upon SGBS cell adipogenic differentiation,
suggesting that elevated ORP2 expression is not essential for
adipocyte lipid storage.
In summary, we report the expression patterns of OSBP/ORPs
in human s.c. and visceral adipose depots and present, by using the
SGBS preadipocyte/adipocyte model, the first data on the
functional role of ORP proteins in adipocyte differentiation.
Supporting Information
Figure S1 Bioinformatic analysis of ORP mRNA expres-
sion in different tissues/cell types. A heat map presentation
based on the microarray data set of Human U133A/GNF1H
Gene Atlas from BioGPS web site (http://biogps.org/
downloads/ ).
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